$ISRG

Intuitive Wins Potential $420M DLA Surgical Robot Supply IDIQ - GovCon Wire

Intuitive Surgical (ISRG) won a potential $420M contract from the Defense Logistics Agency to supply surgical robots and related equipment over five years. The contract was awarded through a competitive process and will be funded through FY 2025. Work will be performed in California.

Original reporting
Published Sep 8, 2026, 11:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 12:22 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ISRG
Bullish
high confidence
Mentioned
$ISRG
Relevance
9/10
AlphAI data visualization · based on govconwire.com
Decision brief

The 30-second read

$ISRGBullishHigh
01

Why it matters

The $420M indefinite‑delivery contract could add several hundred million dollars in revenue over five years.

02

Market read

New federal contract is a material catalyst for ISRG, likely driving short‑term price appreciation.

03

What to watch

Potential competition from other robotic‑surgery vendors and budget constraints at DLA.

Relevance 9/10Novelty 9/10Timing: today

Background

Intuitive Surgical (ISRG) is a leading developer of Da Vinci and Ion surgical robots.

Company-level read

Ticker impact

$ISRGBullishHigh confidence
Context

Intuitive Surgical awarded a potential $420M DLA contract for surgical robots.

Expected impact

potential upside as investors price in new revenue stream

Evidence & confidence

Large government contract adds stable cash flow and validates technology, likely supporting share price.

Market effects

Strengthens demand outlook for medical‑robotics and health‑tech sector.

Positive for U.S. defense‑related procurement market.

Highlights growing government spend on advanced surgical systems worldwide.

Counterpoint

Contract may be delayed or reduced, limiting revenue impact.

Key entities

  • Intuitive Surgical

    US‑listed medical‑technology firm (NASDAQ: ISRG).

  • Defense Logistics Agency

    U.S. Department of Defense procurement arm awarding the contract.

Related articles

$ISRGMedAI 8/10

Intuitive Surgical Sinks 6% as U.S. da Vinci Growth Slows to “Lowest We’ve Seen Since COVID”

Intuitive Surgical (ISRG) shares dropped 6% after reporting Q3 revenue of $3.05B, adjusted EPS of $3.00, and U.S. da Vinci procedure growth of 10%, the lowest since COVID. The company narrowed its 2026 procedure growth outlook and took a $450M antitrust charge. Management plans to cut instrument and accessory revenue per procedure by 3%-5% to boost volume.

$ISRGMedAI 8/10

Intuitive’s US da Vinci procedure growth slows again

Intuitive Surgical reported Q3 revenue of $3.05B, up 22% YoY, with net income of $523M. U.S. da Vinci procedure growth slowed to 10%, the lowest since the pandemic. CEO David Rosa cited adoption challenges in benign general surgery. The company cut instrument prices to boost adoption in high-volume procedures, reducing near-term revenue per procedure. Intuitive adjusted its 2026 da Vinci procedure growth forecast to 14-15%.